38 related articles for article (PubMed ID: 10083391)
21. Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies.
Cobbold SP; Qin S; Leong LY; Martin G; Waldmann H
Immunol Rev; 1992 Oct; 129():165-201. PubMed ID: 1464419
[No Abstract] [Full Text] [Related]
22. Monoclonal antibodies as agents to reinduce tolerance in autoimmunity.
Waldmann H; Qin S; Cobbold S
J Autoimmun; 1992 Apr; 5 Suppl A():93-102. PubMed ID: 1503639
[No Abstract] [Full Text] [Related]
23. Basic and clinical considerations in the use of xenografts.
Markmann JF; Barker CF
Curr Probl Surg; 1994 May; 31(5):387-460. PubMed ID: 8156829
[No Abstract] [Full Text] [Related]
24. Chicken CD4, CD8alphabeta, and CD8alphaalpha T cell co-receptor molecules.
Luhtala M
Poult Sci; 1998 Dec; 77(12):1858-73. PubMed ID: 9872590
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibodies to CD4.
Breedveld FC
Rheum Dis Clin North Am; 1998 Aug; 24(3):567-78. PubMed ID: 9710887
[TBL] [Abstract][Full Text] [Related]
26. A rational design approach for developing immunomodulators based on CD4 and CD8.
Tretiakova AP; Albert RH; Jameson BA
Biotechnol Genet Eng Rev; 2002; 19():175-203. PubMed ID: 12520878
[No Abstract] [Full Text] [Related]
27. Soluble CD4/CD8 molecules in rheumatic disorders.
Sawada S; Takei M; Mitamura K
Clin Immunol Immunopathol; 1994 Aug; 72(2):177-80. PubMed ID: 8050190
[TBL] [Abstract][Full Text] [Related]
28. Anti-CD4 monoclonal antibody therapy in human autoimmune diseases.
Schulze-Koops H; Lipsky PE
Curr Dir Autoimmun; 2000; 2():24-49. PubMed ID: 11791458
[No Abstract] [Full Text] [Related]
29. The epigenetic landscape of lineage choice: lessons from the heritability of CD4 and CD8 expression.
Gialitakis M; Sellars M; Littman DR
Curr Top Microbiol Immunol; 2012; 356():165-88. PubMed ID: 21989924
[TBL] [Abstract][Full Text] [Related]
30. Anti-CD4 monoclonal antibodies in therapy: creation of nonclassical tolerance in the adult.
Shizuru JA; Alters SE; Fathman CG
Immunol Rev; 1992 Oct; 129():105-30. PubMed ID: 1361179
[No Abstract] [Full Text] [Related]
31. Immunointervention in psoriasis with anti-CD4 antibodies.
Thivolet J; Nicolas JF
Int J Dermatol; 1994 May; 33(5):327-32. PubMed ID: 7913701
[No Abstract] [Full Text] [Related]
32. CD4 monoclonal antibodies in organ transplantation--a review of progress.
Sablinski T; Hancock WW; Tilney NL; Kupiec-Weglinski JW
Transplantation; 1991 Oct; 52(4):579-89. PubMed ID: 1926337
[No Abstract] [Full Text] [Related]
33. Rejection of discordant skin xenografts by CD4- CD8- TCR alpha beta+ cells in CD4- and CD8-deficient mice.
Umesue M; Mayumi H; Kong YY; Omoto K; Muranaka H; Nakanishi R; Kohno H; Yasumoto K; Kishihara K; Nomoto K
Transplant Proc; 1999; 31(1-2):890-1. PubMed ID: 10083391
[No Abstract] [Full Text] [Related]
34. The use of CD4 and CD8 knockout mice to study the role of T-cell subsets in allotransplant rejection.
Krieger NR; Fathman CG
J Heart Lung Transplant; 1997 Mar; 16(3):263-7. PubMed ID: 9087868
[No Abstract] [Full Text] [Related]
35. Porcine peripheral blood CD4+/CD8+ dual expressing T-cells.
Pescovitz MD; Sakopoulos AG; Gaddy JA; Husmann RJ; Zuckermann FA
Vet Immunol Immunopathol; 1994 Oct; 43(1-3):53-62. PubMed ID: 7856064
[TBL] [Abstract][Full Text] [Related]
36. T cell development: bottoms-up.
Hedrick SM
Immunity; 2002 May; 16(5):619-22. PubMed ID: 12049714
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8.
Cobbold SP; Adams E; Marshall SE; Davies JD; Waldmann H
Immunol Rev; 1996 Feb; 149():5-33. PubMed ID: 9005219
[TBL] [Abstract][Full Text] [Related]
38. Reconstitution of SCID mice with low numbers of CD4+ TCR alpha beta + T cells.
Reimann J; Rudolphi A; Claesson MH
Res Immunol; 1994 Jun; 145(5):332-7. PubMed ID: 7701110
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
